Circulating nucleic acids (CNAs) and cancer—a survey
M Fleischhacker, B Schmidt - Biochimica et Biophysica Acta (BBA)-Reviews …, 2007 - Elsevier
It has been known for decades that it is possible to detect small amounts of extracellular
nucleic acids in plasma and serum of healthy and diseased human beings. The unequivocal …
nucleic acids in plasma and serum of healthy and diseased human beings. The unequivocal …
Cancer biomarkers-current perspectives
In the recent years, knowledge about cancer biomarkers has increased tremendously
providing great opportunities for improving the management of cancer patients by …
providing great opportunities for improving the management of cancer patients by …
The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases
Epstein-Barr virus (EBV) is a ubiquitous virus that establishes a latent infection within the
host and in some cases can lead to the development of EBV-associated lymphomas …
host and in some cases can lead to the development of EBV-associated lymphomas …
Laboratory assays for Epstein-Barr virus-related disease
ML Gulley, W Tang - The Journal of molecular diagnostics, 2008 - Elsevier
Epstein-Barr virus (EBV) infects various cell types in a wide spectrum of benign and
malignant diseases. Laboratory tests for EBV have improved and are increasingly used in …
malignant diseases. Laboratory tests for EBV have improved and are increasingly used in …
Biomarkers in cancer detection, diagnosis, and prognosis
Biomarkers are vital in healthcare as they provide valuable insights into disease diagnosis,
prognosis, treatment response, and personalized medicine. They serve as objective …
prognosis, treatment response, and personalized medicine. They serve as objective …
Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from …
R Al Hamed, AH Bazarbachi, M Mohty - Bone marrow transplantation, 2020 - nature.com
Epstein-Barr virus (EBV) is a ubiquitous herpes virus that infects the majority of the
population worldwide. The virus can establish a lifelong latent infection in host B …
population worldwide. The virus can establish a lifelong latent infection in host B …
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin …
MK Gandhi, E Lambley, J Duraiswamy, U Dua, C Smith… - Blood, 2006 - ashpublications.org
In Hodgkin lymphoma (HL), the malignant Hodgkin Reed-Sternberg (HRS) cells constitute
only 0.5% of 10% of the diseased tissue. The surrounding cellular infiltrate is enriched with T …
only 0.5% of 10% of the diseased tissue. The surrounding cellular infiltrate is enriched with T …
Prospective measurement of Epstein-Barr virus–DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
R Suzuki, M Yamaguchi, K Izutsu… - Blood, The Journal …, 2011 - ashpublications.org
Abstract Epstein-Barr virus (EBV)–DNA was prospectively analyzed in plasma and
mononuclear cells (MNCs) from peripheral blood in patients with extranodal natural killer …
mononuclear cells (MNCs) from peripheral blood in patients with extranodal natural killer …
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial
JA Kanakry, H Li, LL Gellert, MV Lemas… - Blood, The Journal …, 2013 - ashpublications.org
Epstein-Barr virus (EBV) is associated with Hodgkin lymphoma (HL) and can be detected by
in situ hybridization (ISH) of viral nucleic acid (EBER) in tumor cells. We sought to determine …
in situ hybridization (ISH) of viral nucleic acid (EBER) in tumor cells. We sought to determine …
Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma
K Jones, JP Nourse, C Keane, A Bhatnagar… - Clinical cancer …, 2014 - AACR
Abstract Purpose: Although microRNAs (miRNA) show potential as diagnostic biomarkers in
cancer, their role as circulating cell-free disease response biomarkers remains unknown …
cancer, their role as circulating cell-free disease response biomarkers remains unknown …